Treace Medical Concepts (TMCI) Cash from Investing Activities (2020 - 2025)
Treace Medical Concepts' Cash from Investing Activities history spans 6 years, with the latest figure at $9.7 million for Q4 2025.
- For Q4 2025, Cash from Investing Activities rose 182.55% year-over-year to $9.7 million; the TTM value through Dec 2025 reached $13.3 million, down 62.54%, while the annual FY2025 figure was $13.3 million, 62.54% down from the prior year.
- Cash from Investing Activities reached $9.7 million in Q4 2025 per TMCI's latest filing, up from $8.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $22.4 million in Q2 2024 to a low of -$80.5 million in Q1 2023.
- Average Cash from Investing Activities over 5 years is -$5.6 million, with a median of -$785000.0 recorded in 2021.
- Peak YoY movement for Cash from Investing Activities: crashed 7012.44% in 2022, then surged 315.23% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$900000.0 in 2021, then plummeted by 7012.44% to -$64.0 million in 2022, then soared by 107.82% to $5.0 million in 2023, then tumbled by 31.68% to $3.4 million in 2024, then surged by 182.55% to $9.7 million in 2025.
- Per Business Quant, the three most recent readings for TMCI's Cash from Investing Activities are $9.7 million (Q4 2025), $8.7 million (Q3 2025), and -$3.3 million (Q2 2025).